Literature DB >> 16908357

Sildenafil for the treatment of Raynaud's phenomenon.

Warren R Heymann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16908357     DOI： 10.1016/j.jaad.2006.04.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

3.  Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Authors:  Wendy Ky Ng; Yishai Rosenblatt; Gerald B Brock; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2010

4.  Loss of digits after trauma in a patient with systemic lupus erythematosus.

Authors:  Heidee Villanueva; Marius Tijunelis; Sharon Shapiro; Sean O Henderson
Journal:  West J Emerg Med       Date:  2008-01

Review 5.  Raynaud's Phenomenon with Focus on Systemic Sclerosis.

Authors:  Magdalena Maciejewska; Mariusz Sikora; Cezary Maciejewski; Rosanna Alda-Malicka; Joanna Czuwara; Lidia Rudnicka
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.